216 related articles for article (PubMed ID: 36561992)
1. Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses.
Wang N; Zuo Y; Wu S; Huang C; Zhang L; Zhu D
Acta Pharm Sin B; 2022 Dec; 12(12):4486-4500. PubMed ID: 36561992
[TBL] [Abstract][Full Text] [Related]
2. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
Zhu D; Hu C; Fan F; Qin Y; Huang C; Zhang Z; Lu L; Wang H; Sun H; Leng X; Wang C; Kong D; Zhang L
Biomaterials; 2019 Jun; 206():25-40. PubMed ID: 30925286
[TBL] [Abstract][Full Text] [Related]
4. Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses.
Pan L; Zhang L; Deng W; Lou J; Gao X; Lou X; Liu Y; Yao X; Sheng Y; Yan Y; Ni C; Wang M; Tian C; Wang F; Qin Z
J Control Release; 2023 May; 357():133-148. PubMed ID: 36972863
[TBL] [Abstract][Full Text] [Related]
5. Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient
Ebrahimian M; Hashemi M; Maleki M; Hashemitabar G; Abnous K; Ramezani M; Haghparast A
Front Immunol; 2017; 8():1077. PubMed ID: 28955328
[TBL] [Abstract][Full Text] [Related]
6. Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy.
Li R; Hao Y; Pan W; Wang W; Min Y
Acta Biomater; 2023 Nov; 171():482-494. PubMed ID: 37708924
[TBL] [Abstract][Full Text] [Related]
7. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists.
Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT
ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282
[TBL] [Abstract][Full Text] [Related]
8. Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy.
Kuai R; Sun X; Yuan W; Ochyl LJ; Xu Y; Hassani Najafabadi A; Scheetz L; Yu MZ; Balwani I; Schwendeman A; Moon JJ
J Control Release; 2018 Jul; 282():131-139. PubMed ID: 29702142
[TBL] [Abstract][Full Text] [Related]
9. Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo.
Luo Z; Wang C; Yi H; Li P; Pan H; Liu L; Cai L; Ma Y
Biomaterials; 2015 Jan; 38():50-60. PubMed ID: 25457983
[TBL] [Abstract][Full Text] [Related]
10. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy.
Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W
Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic virus-like mesoporous silica nanoparticles improved cellular internalization for co-delivery of antigen and agonist to enhance Tumor immunotherapy.
Gao Y; Zhang Y; Xia H; Ren Y; Zhang H; Huang S; Li M; Wang Y; Li H; Liu H
Drug Deliv; 2023 Dec; 30(1):2183814. PubMed ID: 36843529
[TBL] [Abstract][Full Text] [Related]
12. Facile preparation of a metal-phenolic network-based lymph node targeting nanovaccine for antitumor immunotherapy.
Su Q; Liu Z; Du R; Chen X; Chen L; Fu Z; Luo X; Yang Y; Shi X
Acta Biomater; 2023 Mar; 158():510-524. PubMed ID: 36603733
[TBL] [Abstract][Full Text] [Related]
13. Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses.
Li C; Zhang X; Chen Q; Zhang J; Li W; Hu H; Zhao X; Qiao M; Chen D
ACS Appl Mater Interfaces; 2018 Jan; 10(3):2874-2889. PubMed ID: 29285934
[TBL] [Abstract][Full Text] [Related]
14.
Yang J; Dong X; Li B; Chen T; Yu B; Wang X; Dou X; Peng B; Hu Q
Front Bioeng Biotechnol; 2022; 10():1050077. PubMed ID: 36727039
[No Abstract] [Full Text] [Related]
15. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
[TBL] [Abstract][Full Text] [Related]
16. An allergen-fused dendritic cell-binding peptide enhances in vitro proliferation of equine T-cells and cytokine production.
Ziegler A; Olzhausen J; Hamza E; Stojiljkovic A; Stoffel MH; Garbani M; Rhyner C; Marti E
Vet Immunol Immunopathol; 2022 Jan; 243():110351. PubMed ID: 34800874
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of TLR7/8 Agonist-Conjugated Antigen Nanoparticles for Cancer Immunotherapy.
Wang N; Zhang G; Zhang P; Zhao K; Tian Y; Cui J
Adv Healthc Mater; 2023 Sep; 12(22):e2300249. PubMed ID: 37016572
[TBL] [Abstract][Full Text] [Related]
18. Self-adjuvant Astragalus polysaccharide-based nanovaccines for enhanced tumor immunotherapy: a novel delivery system candidate for tumor vaccines.
Li N; Zhang Y; Han M; Liu T; Wu J; Xiong Y; Fan Y; Ye F; Jin B; Zhang Y; Sun G; Sun X; Dong Z
Sci China Life Sci; 2024 Apr; 67(4):680-697. PubMed ID: 38206438
[TBL] [Abstract][Full Text] [Related]
19. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
[TBL] [Abstract][Full Text] [Related]
20. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
